Use of at least one lipoaminoacid as an intestinal or pulmonary absorption promoter in a composition for oral or pulmonary administration comprises a combination of fatty acid and natural, synthetic or modified aminoacid

摘要

Use of at least one lipoaminoacid (I) as an intestinal or pulmonary absorption promoter in an active agent-containing pharmaceutical composition for oral or pulmonary administration, where (I) is an optionally salified combination of a 4-40C fatty acid (II) and a natural, synthetic or modified aminoacid (III). An Independent claim is also included for a dispersed pharmaceutical system for oral, pulmonary, cutaneous or transmucosal administration, comprising an active agent, (I) (as absorption promoter), continuous and dispersed phases, emulsifier(s) and a free or esterified fatty acid.